New Confirmatory Study Suggests Progress in Applied Therapeutics–FDA Alignment for Rare Disease Drug on September 29, 2025 Apply Clinical Trials CMT-SORD confirmatory study Govorestat Infrequent regulatory alignment United States Food and Drug Administration +
Applied Therapeutics' Rare Disease Drug Fails Another Phase 3 Trial After FDA Rejection on May 19, 2025 Aldose Reductase Inhibitor Apply Cautionary Warning Classical galactosemia clinical trial conduct Govorestat Infrequent rejection United States Food and Drug Administration +